| P50 | author | Yi Yang | Q91349081 |
| P2093 | author name string | Tongguo Si | |
| P2860 | cites work | Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients | Q26799469 |
| | Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma | Q48058236 |
| | Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. | Q51593250 |
| | Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma. | Q53216812 |
| | Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study | Q57763422 |
| | A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization | Q84121312 |
| | Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma | Q85064441 |
| | Short-term follow-up of radioembolization with yttrium-90 microspheres before liver transplantation: new perspectives in advanced hepatocellular carcinoma | Q85230990 |
| | Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis | Q85508799 |
| | Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? | Q27025083 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Measuring inconsistency in meta-analyses | Q27860655 |
| | EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 |
| | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 |
| | Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization | Q28111719 |
| | Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma | Q28314897 |
| | Hepatocellular carcinoma | Q29615765 |
| | Hepatocellular carcinoma | Q29616359 |
| | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 |
| | Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 |
| | Reporting results of cancer treatment | Q29620070 |
| | Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial | Q33414645 |
| | Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study | Q33691454 |
| | Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection | Q34077181 |
| | Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma | Q34089023 |
| | Novel advancements in the management of hepatocellular carcinoma in 2008. | Q34588842 |
| | Radioembolization for hepatocellular carcinoma | Q34631431 |
| | Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis | Q34874473 |
| | Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 |
| | Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma. | Q35164855 |
| | CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment | Q35193958 |
| | Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. | Q36481071 |
| | Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. | Q36673829 |
| | Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives | Q37068157 |
| | Modified RECIST (mRECIST) assessment for hepatocellular carcinoma | Q37696396 |
| | Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how? | Q37897397 |
| | Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions | Q38080501 |
| | 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness | Q38162894 |
| | The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. | Q38217657 |
| | Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis | Q38883028 |
| | In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 |
| | Comparison of survival, safety, and efficacy after transarterial chemoembolization and radioembolization of Barcelona Clinic Liver Cancer stage B-C hepatocellular cancer patients | Q40893720 |
| | Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study. | Q45985401 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| | systematic review | Q1504425 |
| | cancer research | Q3421914 |
| | yttrium | Q941 |
| P304 | page(s) | 299-310 | |
| P577 | publication date | 2018-08-01 | |
| P1433 | published in | Cancer Biology & Medicine | Q26841841 |
| P1476 | title | Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis | |
| P478 | volume | 15 | |